Concepedia

Publication | Closed Access

A phase I study of binimetinib (MEK 162), a MEK inhibitor, plus carboplatin and pemetrexed chemotherapy in non-squamous non-small cell lung cancer

DOI

16

Citations

22

References

2021

Year

Andrea S. Fung, Donna M. Graham, Eric X. Chen, Tracy Stockley, Tong Zhang, Lisa W. Le, Hamzeh Albaba, Katherine M.W. Pisters, Penelope A. Bradbury, Martina Trinkaus,
Lung Cancer

References

YearCitations

Page 1